Neos Therapeutics, Inc
NEOS
NEOS was delisted on the 19th of March, 2021.
47 hedge funds and large institutions have $66.8M invested in Neos Therapeutics, Inc in 2016 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 16 increasing their positions, 13 reducing their positions, and 7 closing their positions.
29% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 7
23% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 13
4% more funds holding
Funds holding: 45 → 47 (+2)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
24% less capital invested
Capital invested by funds: $88.4M → $66.8M (-$21.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Sio Capital Management
New York
|
+$5.36M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.4M |
| 3 |
HCM
Hodges Capital Management
Dallas,
Texas
|
+$1.05M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$362K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$220K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$3.04M |
| 2 |
DA
DSC Advisors
Chicago,
Illinois
|
-$2.58M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$1.38M |
| 4 |
Renaissance Technologies
New York
|
-$609K |
| 5 |
Franklin Resources
San Mateo,
California
|
-$562K |
NEOS Hedge Fund Activity: Q1 2016 in Review
47 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Neos Therapeutics, Inc (NEOS) for Q1 2016, worth a combined $66.8M — down 24% from $88.4M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new NEOS positions and 7 closed out — a net gain of 2 holders — while 16 added to existing stakes and 13 trimmed.
The largest buyer was Sio Capital Management, adding an estimated $5.36M. The largest seller was Adage Capital Partners, exiting entirely with an estimated $3.04M sold.
- 47 institutional investors held Neos Therapeutics, Inc (NEOS) as of Q1 2016, up from 45 in Q4 2015.
- Funds reported $66.8M of Neos Therapeutics, Inc stock for Q1 2016, down 24% quarter-over-quarter.
- 9 funds opened new Neos Therapeutics, Inc positions in Q1 2016 and 7 closed out, a net change of +2 holders.
- The largest Neos Therapeutics, Inc buyer in Q1 2016 was Sio Capital Management, an estimated $5.36M added.
- The largest Neos Therapeutics, Inc seller in Q1 2016 was Adage Capital Partners, an estimated $3.04M sold.
Based on aggregated 13F filings for Q1 2016.